Trials / Recruiting
RecruitingNCT06703632
Evaluation of PreveCol's Efficiency As a Second Line Method for the Early Colorectal Cancer Detection
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 4,538 (estimated)
- Sponsor
- ADVANCED MARKER DISCOVERY S.L. · Industry
- Sex
- All
- Age
- 50 Years – 69 Years
- Healthy volunteers
- Accepted
Summary
The objective of this low-risk interventional study is to evaluate whether the PreveCol® test has sufficient efficiency to be considered as a second-line method for the detection of both colorectal cancer and advanced adenomas when used prospectively in the screening population with a previous positive FOBT result, which could include any of the following: both sexes, age 50-69 years, asympthomatic volunteers. The main aims to be answered are: * Values of efficacy, efficiency, impact and safety of PreveCol. * Values of preferences of participants for screening methods. * Values of PREMs into screening programme. Participants will provide a blood sample prior to a screening colonoscopy, and complete two questionnaires. They will give their sample, information and clinical data to the investigator or health care personnel.
Conditions
- Screening for Colon Cancer
- Blood Samples
- Survey and Questionnaire
- Colorectal Carcinoma
- Colon Adenocarcinoma
- Precancerous Lesion of Colon
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | blood sampling | PreveCol test based on blood sampling |
| OTHER | Survey using a questionnaire. | Preference questionnaire for colorectal cancer screening methods |
| OTHER | Survey using a questionnaire. | PREMs for colorectal cancer screening programme |
Timeline
- Start date
- 2025-01-14
- Primary completion
- 2025-11-01
- Completion
- 2025-12-01
- First posted
- 2024-11-25
- Last updated
- 2025-02-27
Locations
2 sites across 2 countries: Portugal, Spain
Source: ClinicalTrials.gov record NCT06703632. Inclusion in this directory is not an endorsement.